Every year, nearly 795,000 Americans suffer a stroke—but up to 30% miss their critical treatment window due to delayed or incomplete diagnosis. In this groundbreaking episode of State of Medtech, NeuraSignal’s CEO and co-founder, Dr. Robert Hamilton, dives into the urgent challenges and transformative innovations redefining stroke care.

Key Topics Covered:

• The Bottleneck in Stroke Diagnosis
  Why transcranial Doppler (TCD), a proven cerebral blood flow monitoring method, has remained stuck in academic use—and how NeuraSignal is changing that.

• AI + Robotics in the ER
  How automated stroke detection technology is enabling real-time diagnostics within minutes, improving triage speed and outcomes.

• The Cryptogenic Stroke Crisis
  Learn why up to 80% of community hospitals struggle to identify the cause of stroke—and how current tools miss 2 out of 3 patent foramen ovale (PFO) cases.

• Clinical and Regulatory Insight
  Dr. Hamilton shares NeuraSignal’s latest clinical results, regulatory strategy, and what it takes to bring bedside brain monitoring to every emergency department.

Who Should Watch:

If you’re an investor, neurologist, emergency clinician, or medtech innovator, this interview is essential listening. Gain insight into where the field is headed and why NeuraSignal’s approach could redefine the stroke diagnosis standard.